José María Huch Ginesta

José María Huch Ginesta, listed as finance chief, appears in our data through filings on Atrys Health, S.A. shares, published by CNMV. The record holds 10 filings, for trades running from 15 June 2022 to 9 April 2026.

On the open market, the record shows 8 purchases worth €99k and 2 sales worth €9.4M. On balance, insiders were net sellers of €9.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €5,170. Relative to company size, the median is 0.0024% of market cap (5 purchases with a known value). Clusters matter here: 6 out of 8 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

On 10 April 2026 came the latest disclosure, an open-market sale for €11k in Atrys Health, S.A. The latest purchase dates back some time: it was published 1,062 days ago, on 21 November 2023. Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from CNMV. Past trades are no guide to future returns.